title: Re: Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.
authors.affiliation: Division of Nephrology, Tehran University of Medical Sciences, Tehran, Iran. ahmadifa@tums.ac.ir.
authors.forename: Farrokhlagha
authors.initials: F
authors.lastname: Ahmadi
authors.forename: Azin
authors.initials: A
authors.lastname: Mohebi-Nejad
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D020738:Leptin / Q000378:metabolism*; D008148:Lovastatin / Q000627:therapeutic use*; D008297:Male
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D020738:Leptin; D008148:Lovastatin